Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - The page now displays Revision: v3.5.4, replacing Revision: v3.5.3, indicating a minor update to the page content or layout.
    Difference
    0.1%
    Check dated 2026-05-15T15:16:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows an updated “Revision” version indicator, changing from v3.5.2 to v3.5.3 without affecting the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:02:18.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:10.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:00:11.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page displays Revision: v3.4.3, replacing Revision: v3.4.2. No study content or functionality is altered.
    Difference
    0.1%
    Check dated 2026-03-11T23:41:10.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; notices about government funding lapses and the prior v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:07:21.000Z thumbnail image

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.